• News
  • SAN DIEGO
  • Finance

Daily Digest

The Daily Digest intends to help readers track major announcements made by and about companies on the San Diego Stock Exchange Index. The Daily Digest tracks announcements and SEC filings released from midnight until 4 p.m., or three hours after the stock markets close. To see how companies on the San Diego Stock Exchange Index performed, visit sddt.com/stocks.

Acadia Pharmaceuticals Inc.: Company announced a private placement equity financing pursuant to which it will receive gross proceeds of $86.4 million from the sale of its securities.

Aethlon Medical Inc.: Company announced a compassionate-use clinical program, which provides HCV-infected patients with access to Hemopurifier therapy, has been expanded to include patients who experience a viral breakthrough during standard-of-care drug therapy.

AMN Healthcare Services Inc.: Company announced it has increased the size of its board to eight, and appointed Mark Foletta as a new director, effective immediately.

Life Technologies Corp.: SEC documents showed Director Bradley Lorimer exercised options on 20,000 shares at $15.04 per share, and sold 20,000 shares at $51.04 to $51.11 per share on Tuesday.

Pure Bioscience: Company announced a net loss of $2.2 million, or 25 cents per share, for the quarter ended Oct. 31.

Volcano Corp.: Company was downgraded to “neutral” from “outperform” by brokerage firm Credit Suisse. The target price is $27 per share.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.